Recommendations of the Spanish Society of Rheumatology on Treatment and Use of Systemic Biological and Non-biological Therapies in Psoriatic Arthritis

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

Laure Gossec, Josef S Smolen, Sofía Ramiro et al. · Annals of the Rheumatic Diseases · 2016 · 913 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Laura C. Coates, Arthur Kavanaugh, Philip J. Mease et al. · Arthritis & Rheumatology · 2016 · 904 citations · Full text

Medicine, Clinical Sciences, Dermatology +13

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

Philip J. Mease, Alan Kivitz, Francis X. Burch et al. · Arthritis & Rheumatism · 2004 · 887 citations

Medicine, Pharmacotherapy, Dermatopathology +10